Shareholders for Walgreens Boots Alliance overwhelmingly voted to approve the company’s sale to Sycamore Partners, with 96% of shareholders at a special meeting voting to green-light the merger, ...

Key Points Walgreens is an iconic brand in the pharmacy space, but it has fallen on hard times.The retailer has agreed to be ...

The transaction, expected to close in Q3 or Q4, will take the company private after nearly 100 years as a public company.

Walgreens Boots Alliance is going private at $11.45/share plus up to $3 via a CVR, offering a potential $14.45 payout. See ...

Walgreens Boots Alliance is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 175-year heritage of caring for communities.

Walgreens Boots Alliance shareholders approved the company’s sale to private equity firm Sycamore Partners at a July 11 special meeting. Walgreens announced in March that it had entered into a ...

By overwhelmingly approving the $10 billion sale to private-equity firm Sycamore Partners, investors set an official end date on Walgreens’ run as one of Chicago’s most iconic public companies ...

Walgreens Boots Alliance (NASDAQ:WBA) is set to announce second quarter earnings on Tuesday and investors will focus on details of the sale progress about the company’s $10 billion deal to go ...

Walgreens Boots Alliance reported adjusted earnings per share of 38 cents for the third quarter of its 2025 fiscal year, which beat Zacks Investment Research's estimate of 34 cents per share.

This would represent the third attempted sale of Boots since 2022. WBA previously sought a £7bn sale but withdrew after ...

Walgreens’ third-quarter performance comes ahead of its $10 billion sale to private equity firm Sycamore Partners, expected to close by the end of 2025. The looming transaction has created ...